Warning: This security is no longer trading.
Gilead Sciences Completes Acquisition of Kite Pharma, Inc.
Kite Pharma, Inc. (KITE): Price and Financial Metrics
KITE Price/Volume Stats
| Current price | $179.99 | 52-week high | $179.99 |
| Prev. close | $179.79 | 52-week low | $39.82 |
| Day low | $179.99 | Volume | 100 |
| Day high | $179.99 | Avg. volume | 1,652,408 |
| 50-day MA | $151.18 | Dividend yield | N/A |
| 200-day MA | $92.97 | Market Cap | 10.33B |
KITE Stock Price Chart Interactive Chart >
Kite Pharma, Inc. (KITE) Company Bio
Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy designed to restore the immune system's ability to recognize and eradicate tumors. The company was founded in 2009 and is based in Santa Monica, California.
KITE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KITE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |